Of note, ETS homologous factor is reported to be an anti-EMT factor61 and its decreased expression observed in tumor cells supports the finding that basal tumors tend to have increased EMT (epithelial-mesenchymal transition) properties relative to luminal tumors. The gene discussed is EHF; the disease is neoplasm.